$COYA 8-K/A SEC Filings

Filed On	Filing
07 Aug 2026	8-K/A: Departure/Election of Directors or Officers; Compensation This Amendment No. 1 to Current Report on Form 8-K/A (the “Amendment”) amends the Current Report on Form 8-K of Coya Therapeutics, Inc. (the “Company”) dated March 29, 2026 and filed with the Securities and Exchange Commission on April 2...